Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.

Dhoot, Dhiraj; Jain, Gaurav Kumar; Manjhi, Mukesh; Kesharwani, Prashant; Mahadkar, Namrata; Barkate, Hanmant

Dhoot, Dhiraj; Jain, Gaurav Kumar; Manjhi, Mukesh; Kesharwani, Prashant; Mahadkar, Namrata; Barkate, Hanmant.

Afiliação

Dhoot D; Department of Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, India.
Jain GK; Center of Advanced Formulation Technology, Delhi Pharmaceutical Science and Research University, New Delhi, India.
Manjhi M; Department of Dermatology, Hamdard Institute of Medical Sciences and Research, New Delhi, India.
Kesharwani P; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Mahadkar N; Department of Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, India.
Barkate H; Department of Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, India.

Drugs Context ; 122023.

Article em En | MEDLINE | ID: mdl-36660014

Palavras-chave

dermatophytosis; itraconazole; sebum concentration; serum concentration; super-bioavailable itraconazole

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Drugs Context Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google